Recent News
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week with a focus on fingers and better prescriptive follow through.
![](https://pbs.twimg.com/media/GW580mtWAAEXQ8F.jpg)
![](https://pbs.twimg.com/media/GW5hZh8XEAApL8h.jpg)
Links:
![](https://pbs.twimg.com/media/GW4qdliW0AAlq4b.jpg)
![](https://pbs.twimg.com/ext_tw_video_thumb/1832418689280319488/pu/img/mgsths2yA6ICIPL6.jpg)
![](https://pbs.twimg.com/media/GW0X2maXsAAfYo3.jpg)
![](https://pbs.twimg.com/media/GWzg8lLXcAAwoKv.jpg)
![](https://pbs.twimg.com/media/GWzFejtXsAAqBbz.jpg)
CAR-T Like Effects with Bispecific Teclistamab
A new chapter may have begun in the exciting story of "immune reset" therapy for difficult-to-treat autoimmune diseases, with a patient with severe refractory lupus obtaining drug-free remission after treatment with an antibody product normally used in multiple myeloma.
Read ArticleDoes Rheumatoid Factor Influence Anti-TNF Responses in RA?
Smolen and colleagues have published a subanalysis of the EXXELERATE study that showed while certolizumab pegol [CZP] concentrations and efficacy was unaffected by high titers of rheumatoid factor (RF), patients treated with adalimumab had a blunted response in the face of high RF titers.
Read Article![](https://pbs.twimg.com/media/GWwFIztXMAAh1tT.jpg)
![](https://pbs.twimg.com/media/GWvprNQXcAAsDZY.jpg)
![](https://pbs.twimg.com/media/GWvOLmRXoAAdKxN.jpg)
![](https://pbs.twimg.com/media/GWuXfwwXAAAAF4v.jpg)
![](https://pbs.twimg.com/media/GWuLUkZWoAA_x2m.jpg)
![](https://pbs.twimg.com/media/GWt72MhXUAAgzJV.jpg)
Urticarial Vasculitis Overview
Urticarial vasculitis is rare and the causes often go undiagnosed. A Medscape recent overview highlights key features in the diagnosis and management of this rare disorder.
Read Article![](https://pbs.twimg.com/media/GWq7hOdWsAAGUkz.jpg)
![](https://pbs.twimg.com/media/GWqgG4yXYAA6ZPu.jpg)
![](https://pbs.twimg.com/media/GWqEq7UWMAEYp6D.jpg)
![](https://pbs.twimg.com/media/GWppPsiXcAA3g7h.jpg)